
               
               
               7 DRUG INTERACTIONS
               
                  The metabolism of paclitaxel is catalyzed by CYP2C8 and CYP3A4.  Caution should be exercised when administering ABRAXANE concomitantly with medicines known to inhibit (e.g., ketoconazole and other imidazole antifungals, erythromycin, fluoxetine, gemfibrozil, cimetidine, ritonavir, saquinavir, indinavir, and nelfinavir) or induce (e.g., rifampicin, carbamazepine, phenytoin, efavirenz, and nevirapine) either CYP2C8 or CYP3A4.
               
               
               
                  
                     
                        
                           Use caution when concomitantly administering ABRAXANE with inhibitors or inducers of either CYP2C8 or CYP3A4. (7)
                        
                     
                  
               
            
         